References
- Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
- Creese I., Sibley D. R., Hamblin M. W., Leff S. E. The classification of dopamine receptors: relationship to radioligand binding. Annual Review of Neuroscience 1983; 6: 43–71
- Lakin M. L., Miller C. H., Statt M. L., Winters W. D. Involvement of the pineal gland and melatonin in marine analgesia. Life Sciences 1981; 29: 2543–2551
- Lissoni P., Esposito D., Esposito G., Mauri R., Resentini M., Morabito F., Fumagalli P., Santagostino A., Delitala G., Franchini F. A clinical study on the relationship between the pineal gland and the opioid system. Journal of Neural Transmission 1986; 65: 63–73
- Sandyk R., Snider S. R. Naloxone ameliorates levodopa‐induced dyskinesias in Parkinson's Disease. American Journal of Psychiatry 1986; 143: 118
- Sandyk R. The endogenous opioid system in neurological disorders of the basal ganglia. Life Sciences 1985; 37: 1655–1663
- Sandyk R., Fisher H. Attenuation of reserpine‐induced catalepsy by melatonin. 1988, submitted
- Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharmacology 1989; 9: 147–148